Verdence Capital Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
2025
Q4
$274K Sell
2025
Q3
$1.79M Sell
2025
Q2
$3.03M Buy
2025
Q1
$3.04M Sell
2024
Q4
$4.17M Buy
2024
Q3
$5.12M Buy
2024
Q2
$5.16M Sell
2024
Q1
$4.65M Sell
2023
Q4
$3.78M Buy
2023
Q3
$3.02M Buy
2023
Q2
$1.43M Buy
2023
Q1
$645K Buy
2022
Q4
$421K Buy